Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs By Christina Jewett from NYT Health https://ift.tt/4jFBvZg United States International Relations, Drugs (Pharmaceuticals), Factories and Manufacturing, United States Politics and Government, Biotechnology and Bioengineering, Cystic Fibrosis, Cancer, Supply Chain, Intellectual Property, Shortages, Government Contracts and Procurement, Labor and Jobs, Start-ups, Leukemia, Research, Tax Credits, Deductions and Exemptions, AbbVie Inc, Eli Lilly and Company, GlaxoSmithKline PLC, House of Representatives, Janssen Pharmaceutica, People's Liberation Army (China), Senate, WuXi PharmaTech, China, Delaware, Massachusetts